REFLECT real-world evidence (RWE) prospective study update: Efficacy and safety results of Sandoz biosimilar rituximab (SDZ-RTX) for the treatment of diffuse large B-cell lymphoma (DLBCL).

13. Juli 2020

Welslau M, Marschner N, Otremba B, Topaly J, Bittencourt da Silva L, 2020.

HemaSphere 4(S1) (EP1245), 583.